Skip to content

Clinical trials

Terminated Hemorrhage trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hemorrhage Status: Terminated Country / region: Canada Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20072
20091
20151
20161
20171
20191
20201
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated10

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
McMaster University2
Anthos Therapeutics, Inc.1
Canadian Heart Research Centre1
Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal1
GlaxoSmithKline1
Hamilton Health Sciences Corporation1
Idorsia Pharmaceuticals Ltd.1
Pfizer1
Population Health Research Institute1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hemorrhage10
Atrial Fibrillation2
Stroke2
Venous Thromboembolism2
Angina, Unstable1
Arrhythmias, Cardiac1
Blood Loss, Surgical1
Cerebral Hemorrhage1
Hematoma1
Myocardial Infarction1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.